BRUZZONE, BIANCA
 Distribuzione geografica
Continente #
EU - Europa 7.215
AS - Asia 1.159
NA - Nord America 1.058
Continente sconosciuto - Info sul continente non disponibili 200
SA - Sud America 97
AF - Africa 24
OC - Oceania 1
Totale 9.754
Nazione #
IT - Italia 7.009
US - Stati Uniti d'America 973
SG - Singapore 417
CN - Cina 294
VN - Vietnam 222
BD - Bangladesh 85
FR - Francia 63
BR - Brasile 60
HK - Hong Kong 39
CA - Canada 33
DE - Germania 31
GB - Regno Unito 22
FI - Finlandia 21
AR - Argentina 20
MX - Messico 18
IQ - Iraq 14
JP - Giappone 14
IN - India 13
JM - Giamaica 9
PH - Filippine 9
CR - Costa Rica 8
RU - Federazione Russa 7
TH - Thailandia 7
UA - Ucraina 7
ES - Italia 6
PK - Pakistan 6
PL - Polonia 6
EC - Ecuador 5
ID - Indonesia 5
JO - Giordania 5
NL - Olanda 5
TR - Turchia 5
ZA - Sudafrica 5
AT - Austria 4
CH - Svizzera 4
ET - Etiopia 4
HN - Honduras 4
IE - Irlanda 4
RO - Romania 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
VE - Venezuela 4
CL - Cile 3
HR - Croazia 3
HU - Ungheria 3
MA - Marocco 3
SV - El Salvador 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
EG - Egitto 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
IR - Iran 1
KY - Cayman, isole 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SE - Svezia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 9.556
Città #
Genoa 3.033
Genova 2.457
Vado Ligure 698
Rapallo 651
San Jose 235
Singapore 201
Ashburn 115
Ho Chi Minh City 72
Beijing 62
Hanoi 56
Lauterbourg 54
Council Bluffs 53
Hong Kong 36
New York 36
Bordighera 30
Los Angeles 27
Helsinki 21
Frankfurt am Main 19
Santa Clara 19
Buffalo 16
Milan 16
Tokyo 13
Chicago 12
Rome 12
Dallas 10
Haiphong 10
Mexico City 10
Atlanta 9
Boardman 9
Da Nang 9
London 8
Orem 8
Houston 7
Montreal 7
São Paulo 7
Charlotte 6
City of London 6
Florence 6
San José 6
Tianjin 6
Amman 5
Brooklyn 5
Detroit 5
Hải Dương 5
Kyiv 5
Naples 5
Toronto 5
Baghdad 4
Billings 4
Biên Hòa 4
Can Tho 4
Columbus 4
Denver 4
Guangzhou 4
Hangzhou 4
Kingston 4
Las Vegas 4
Paris 4
Queens 4
Tashkent 4
Warsaw 4
Zurich 4
Amsterdam 3
Bangkok 3
Bari 3
Birmingham 3
Chennai 3
Dublin 3
Fresno 3
Gresham 3
Itaquaquecetuba 3
Karbala 3
Modena 3
Nashville 3
Ninh Bình 3
Nuremberg 3
Philadelphia 3
Phoenix 3
Princeton 3
Salt Lake City 3
San Antonio 3
Shenzhen 3
Vinh 3
Washington 3
Zagreb 3
Acalanes Ridge 2
Addis Ababa 2
Albany 2
Auburn 2
Bauru 2
Belleview 2
Bossier City 2
Brasília 2
Bridgetown 2
Budapest 2
Buenos Aires 2
Cairo 2
Campagnano di Roma 2
Cape Coral 2
Cape Town 2
Totale 8.262
Nome #
Fifteen years of epidemiologic, virologic and syndromic influenza surveillance: A focus on type B virus and the effects of vaccine mismatch in Liguria region, Italy 257
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 246
Correct Identification of Dual HCV Infections in HIV/HCV CoInfected Patients 218
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 199
Analysis of a 3-months measles outbreak in western Liguria, Italy: Are hospital safe and healthcare workers reliable? 199
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 196
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 188
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 182
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 181
Bloodstream infections in critically ill patients with COVID-19 180
Overview of hepatitis B virus mutations and their implications in the management of infection 177
Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy 176
Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infection. 163
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group 159
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 159
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy 155
Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study 155
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 154
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 153
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 151
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 150
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 146
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 143
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 142
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 137
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 136
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 136
From a medical mistake to a clinical warning: The case of HBV mutant virus reactivation in haematological patients 136
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 136
Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers 134
Adverse Reactions after the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine among Medical School Residents in a Regional Reference University Hospital in Italy 133
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 133
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 132
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 132
Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: a cross sectional study 132
Unexpected high rate of wild-type HIV-1 genotype among inmates failing antiretroviral therapy 129
Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey 129
Xpert HIV-1 viral load assay and versant HIV-1 RNA 1.5 assay: A performance comparison 126
Comparative Analysis of Five Multiplex RT-PCR Assays in the Screening of SARS-CoV-2 Variants 123
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? 123
Characterization of T lymphocytes in severe COVID-19 patients 123
Comparative diagnostic performance of rapid antigen detection tests for COVID-19 in a hospital setting 122
Comparative Diagnostic Accuracy of the {STANDARD} M10 Assay for the Molecular Diagnosis of {SARS}-{CoV}-2 in the Point-of-Care and Critical Care Settings 119
Determinants of SARS-CoV-2 infection in Italian healthcare workers: a multicenter study 117
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 115
Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA) 115
Comparative diagnostic performance of a novel reverse transcription loop-mediated isothermal amplification (RT-LAMP) kit for the rapid detection of SARS-CoV-2 110
Mortality of Pneumocystis jirovecii pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG 106
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 106
Changes in attitudes and beliefs concerning vaccination and influenza vaccines between the first and second covid-19 pandemic waves: A longitudinal study 106
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 104
Investigating SARS-CoV-2 transmission among co-workers in a University of Northern Italy during COVID-19 pandemic: an observational study 104
Emerging mutations at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine 101
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients 100
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 97
Reactogenicity of bnt162b2 mrna covid-19 vaccine in a young working age population: A survey among medical school residents, within a mass vaccination campaign, in a regional reference teaching hospital in italy 97
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 96
Duration of isolation and precautions in immunocompromised patients with COVID-19 96
Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA) 95
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 94
Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV 93
Co-detection of respiratory pathogens among ILI patients: characterization of samples collected during the 2018/19 and 2019/20 pre-pandemic seasons 92
Outbreak of sars-cov-2 lineage 20i/501y.V1 in a nursing home underlines the crucial role of vaccination in both residents and staff 91
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort 90
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 89
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 88
Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B 85
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 84
Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009 78
Efficacy of the Sentinox Spray in Reducing Viral Load in Mild COVID-19 and Its Virucidal Activity against Other Respiratory Viruses: Results of a Randomized Controlled Trial and an In Vitro Study 73
How Long Can a Dead Body Remain Infectious?: Postmortem Nasopharyngeal Swabs and SARS-CoV-2 Culture in a Corpse Over an 87-Day Period 71
Darunavir-based dual therapy in HIV experienced patients 71
Evaluation of extraction-free RT-qPCR methods for SARS-CoV-2 diagnostics 63
Real-world performance of SARS-CoV-2 rapid antigen testing through the Alpha-, Delta- and Omicron-dominant waves of the COVID-19 pandemic 55
96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: a retrospective cohort study 53
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy 53
Herpes Simplex Virus 1 (HSV-1) Reactivation in Critically Ill COVID-19 Patients: A Brief Narrative Review 21
PREVALENCE OF ETRAVIRINE (ETR)-RESISTANCE ASSOCIATED MUTATIONS AT NNRTI FAILURE AND PREDICTORS OF RESISTANCE TO ETR IN A LARGE ITALIAN RESISTANCE DATABASE (ARCA) 16
A Cluster Randomized Study to Explore Case Definitions, Clinical Course and Consequences of RSV in Community-Dwelling Adults Aged ≥ 50 Years 15
Prevalence of etravirine (ETR)-RAMs at NNRTI failure and predictors of resistance to ETR in a large Italian resistance database (ARCA) 7
Diagnostic Accuracy of Five Molecular Assays for the Detection of Dengue Virus 7
Totale 9.754
Categoria #
all - tutte 36.321
article - articoli 35.856
book - libri 0
conference - conferenze 465
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022597 40 16 23 76 19 33 37 119 64 58 24 88
2022/2023817 73 83 2 68 91 122 8 42 128 50 137 13
2023/2024669 29 72 12 86 66 121 40 48 28 27 46 94
2024/20251.954 58 106 49 143 203 210 253 377 64 94 197 200
2025/20263.429 429 85 313 273 405 197 446 201 316 317 177 270
2026/2027309 309 0 0 0 0 0 0 0 0 0 0 0
Totale 9.754